Enhanced controlled release of loratadine from the ethylene-vinyl acetate matrix containing plasticizer

Drug Delivery

Volumn 15, Issue 7, 2008, Pages 423-428

  Cho, Cheong Weon ^a   Kim, Seong Jin ^b   Yang, Kyu Ho ^c   Song, Jae Haeng ^c   Jeong, Hyun Jon ^c   Shin, Sang Chul ^c  

^a Chungnam National University   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c Chonnam National University   (South Korea)

Author keywords

Enhanced release; Ethylene vinyl acetate; Loratadine; Matrix; Plasticizer

Indexed keywords

CITRIC ACID; CITRIC ACID TRIBUTYL ESTER; CITRIC ACID TRIETHYL ESTER; ETHYLENE VINYL ACETATE COPOLYMER; LORATADINE; MACROGOL 400; PHTHALIC ACID DERIVATIVE; PHTHALIC ACID DIETHYL ESTER; PLASTICIZER;

ANIMAL CELL; AQUEOUS SOLUTION; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG SOLUBILITY; ENERGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; TEMPERATURE;

ADMINISTRATION, CUTANEOUS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRATES; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; EXCIPIENTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; KINETICS; LORATADINE; MEMBRANES, ARTIFICIAL; PERMEABILITY; PHTHALIC ACIDS; PLASTICIZERS; POLYETHYLENE GLYCOLS; POLYVINYLS; SOLUBILITY; TEMPERATURE;

EID: 49949090613     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540802321750     Document Type: Article

References (20)

1. Bodmeier, R., and Paeratakul. O. 1989. Evaluation of drug containing polymer films prepared from aqueous latexes. Pharm. Res. 6:725-730.
2. Chien. Y. W., and Lambert, H. J. 1975. Solubilization of steroids by multiple co-solvent systems. Chem. Pharm. Bull. 23:1085.
3. Chien, Y. W., and Lau, E. P. K. 1976. Controlled drug release from polymeric delivery devices IV. in vitro-in vivo correlation of subcutaneous release of norgestomet from hydrophilic implants. J. Pharm. Sci. 65:488.
4. Crawford, R. R., and Esmerian. O.K. 1971. Effect of plasticizers on some physical properties of cellulose acetate phthalate films. J. Pharm. Sci. 60:312-314.
5. Desai S. J., Singh P., Simonelli. A. P., and Higuchi. W. I. 1966. Factors influencing release of solid drug dispersed in inert matrices III. Quantitative studies involving the polyethylene plastic matrix. J. Pharm. Sci. 55:1230.
6. Entwistle, C. A., and Rowe, R. E. 1979. Plasticization of cellulose ethers used in the film coating of tablets. J. Pharm. Pharmacol. 31:269-272.
7. Eugene. W., and Monroe 1997. Loratadine in the treatment of urticaria. Clin. Therap. 19: 232-242.
8. Farhadieh, B., Boradkin, S., and Buddenhagen. J. 1971. Drug release from methyl acrylate-methyl methacrylate copolymer matrix II: control of release rate by exposure to acetone vapor. J. Pharm. Sci. 60: 212.
9. Figen. T., and Yuce. Z. 2005. Development of transdermal system containing nicotine by using sustained release dosage design. II. Farmaco 60:763-770.
10. Higuchi, T. 1961. Rate of release of medicaments from ointment bases containing drug in suspension. J. Pharm. Sci. 50:874.
11. Higuchi, T. 1963. Mechanism of sustained-action mediation. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52:1145.
12. Jenquin, M. R., Liebowitx, S. M., Sarabia, R. E., and McGinity, J. W. 1990. Physical and chemical factors influencing the release of drugs from acrylic resin films. J. Pharm. Sci. 79: 811-816.
13. Krishnaiah, Y. S. R., Satyananrayana, V., and Bhaskar, P. 2002. Influence of limonene on the bioavailability of nicardipine hydrochloride from membrane-moderated transdermal therapeutic systems in human volunteers. Int. J. Pharm. 247:91-102.
14. Langer, R. 2004. Transdermal drug delivery: past progress, current status, and future prospects. Adv. Drug. Deliv. Rev. 56:557-558.
15. Lapidus, H., and Lordi, N.G. 1966. Some factors affecting the release of a watersoluble drug from compressed hydrophilic procedures. J. Pharm. Sci. 55: 840.
16. Lapidus, H., and Lordi, N.G. 1968. Drug release from compressed hydrophilic matrices. J. Pharm. Sci. 57:1292.
17. Laurian, V., Silvia, I., Dana, M., and Sorin, E. L. 2006. Determination of loratadine and its active metabolite in human plasma by high-performance liquid chromatography with mass spectrometry detection. J. Pharm. Bio.
18. Miyazaki, S., Ishii, K., Sugibayashi, K., Morimoto, Y., and Takada, M. 1982. Antitumor effect of ethylene-vinyl acetate copolymer matrices containing 5-fluorouracil on Ehrlich Ascites carcinoma in mice. chem. Pharm Bull. 30:3770.
19. Siepmann, F., Brun, V.L., and Siepmann, J. 2006. Drugs acting as plasticizers in polymeric systems: a quantitative treatment, J. Cont. Rel. 115:298-306.
20. Singh, P., Desai, S. J., Simonelli. A. P., and Higuchi, W. I. 1967. Release rates of solid drug mixtures dispersed in inert matrices. Noninteracting drug mixtures. J. Pharm. Sci., 56:1542.